1h Free Analyst Time
The publisher has been monitoring the leuprolide acetate market and it is poised to grow by $1.04 bn during 2022-2026, progressing at a CAGR of 7.40% during the forecast period. The report on the leuprolide acetate market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of prostate cancer and the rising availability of funds for research and development.
The leuprolide acetate market analysis includes the end-user segment and geographic landscape.
The leuprolide acetate market is segmented as below:
By End-user
- Hospitals
- Clinics
- Research and academic institutions
By Geographical Landscape
- North America
- Europe
- Asia
- ROW
This study identifies the increasing healthcare expenditures and growing geriatric population as one of the prime reasons driving the leuprolide acetate market growth during the next few years.
The report on leuprolide acetate market covers the following areas:
- Leuprolide acetate market sizing
- Leuprolide acetate market forecast
- Leuprolide acetate market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading leuprolide acetate market vendors that include AbbVie Inc., Astellas Pharma Inc., BACHEM HOLDING AG, Beijing Biote Pharmaceutical Co. Ltd, Livzon Pharmaceutical Group Inc., Merck KGaA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Tolmar Pharmaceuticals Inc., and Varian Pharmed. Also, the leuprolide acetate market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021 - 2026
Five Forces Analysis
- Five forces analysis 2021 & 2026
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by End-user
- Market segments
- Comparison by End-user
- Hospitals - Market size and forecast 2021-2026
- Clinics - Market size and forecast 2021-2026
- Research and academic institutions - Market size and forecast 2021-2026
- Market opportunity by End-user
Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2021-2026
- Europe - Market size and forecast 2021-2026
- Asia - Market size and forecast 2021-2026
- ROW - Market size and forecast 2021-2026
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Landscape disruption
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- AbbVie Inc.
- Astellas Pharma Inc.
- BACHEM HOLDING AG
- Beijing Biote Pharmaceutical Co. Ltd
- Livzon Pharmaceutical Group Inc.
- Merck KGaA
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Tolmar Pharmaceuticals Inc.
- Varian Pharmed
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2021 - 2026 ($ million)
- Global market: Year-over-year growth 2021 - 2026 (%)
- Five forces analysis 2021 & 2026
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2021
- End-user - Market share 2021-2026 (%)
- Comparison by End-user
- Hospitals - Market size and forecast 2021-2026 ($ million)
- Hospitals - Year-over-year growth 2021-2026 (%)
- Clinics - Market size and forecast 2021-2026 ($ million)
- Clinics - Year-over-year growth 2021-2026 (%)
- Research and academic institiutions - Market size and forecast 2021-2026 ($ million)
- Research and academic institiutions - Year-over-year growth 2021-2026 (%)
- Market opportunity by End-user
- Customer landscape
- Market share By Geographical Landscape 2021-2026 (%)
- Geographic comparison
- North America - Market size and forecast 2021-2026 ($ million)
- North America - Year-over-year growth 2021-2026 (%)
- Europe - Market size and forecast 2021-2026 ($ million)
- Europe - Year-over-year growth 2021-2026 (%)
- Asia - Market size and forecast 2021-2026 ($ million)
- Asia - Year-over-year growth 2021-2026 (%)
- ROW - Market size and forecast 2021-2026 ($ million)
- ROW - Year-over-year growth 2021-2026 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- AbbVie Inc. - Overview
- AbbVie Inc. - Product and service
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Key customers
- AbbVie Inc. - Segment focus
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product and service
- Astellas Pharma Inc. - Key offerings
- Astellas Pharma Inc. - Key customers
- Astellas Pharma Inc. - Segment focus
- BACHEM HOLDING AG - Overview
- BACHEM HOLDING AG - Business segments
- BACHEM HOLDING AG - Key offerings
- BACHEM HOLDING AG - Key customers
- BACHEM HOLDING AG - Segment focus
- Beijing Biote Pharmaceutical Co. Ltd - Overview
- Beijing Biote Pharmaceutical Co. Ltd - Product and service
- Beijing Biote Pharmaceutical Co. Ltd - Key offerings
- Beijing Biote Pharmaceutical Co. Ltd - Key customers
- Beijing Biote Pharmaceutical Co. Ltd - Segment focus
- Livzon Pharmaceutical Group Inc. - Overview
- Livzon Pharmaceutical Group Inc. - Business segments
- Livzon Pharmaceutical Group Inc. - Key offerings
- Livzon Pharmaceutical Group Inc. - Key customers
- Livzon Pharmaceutical Group Inc. - Segment focus
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key offerings
- Merck KGaA - Key customers
- Merck KGaA - Segment focus
- Sun Pharmaceutical Industries Ltd. - Overview
- Sun Pharmaceutical Industries Ltd. - Product and service
- Sun Pharmaceutical Industries Ltd. - Key offerings
- Sun Pharmaceutical Industries Ltd. - Key customers
- Sun Pharmaceutical Industries Ltd. - Segment focus
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product and service
- Takeda Pharmaceutical Co. Ltd. - Key offerings
- Takeda Pharmaceutical Co. Ltd. - Key customers
- Takeda Pharmaceutical Co. Ltd. - Segment focus
- Tolmar Pharmaceuticals Inc. - Overview
- Tolmar Pharmaceuticals Inc. - Product and service
- Tolmar Pharmaceuticals Inc. - Key offerings
- Tolmar Pharmaceuticals Inc. - Key customers
- Tolmar Pharmaceuticals Inc. - Segment focus
- Varian Pharmed - Overview
- Varian Pharmed - Product and service
- Varian Pharmed - Key offerings
- Varian Pharmed - Key customers
- Varian Pharmed - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global leuprolide acetate market: AbbVie Inc., Astellas Pharma Inc., BACHEM HOLDING AG, Beijing Biote Pharmaceutical Co. Ltd, Livzon Pharmaceutical Group Inc., Merck KGaA, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Tolmar Pharmaceuticals Inc., and Varian Pharmed.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing healthcare expenditures and growing geriatric population.`
According to the report, one of the major drivers for this market is the increasing prevalence of prostate cancer.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Astellas Pharma Inc.
- BACHEM HOLDING AG
- Beijing Biote Pharmaceutical Co. Ltd
- Livzon Pharmaceutical Group Inc.
- Merck KGaA
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Tolmar Pharmaceuticals Inc.
- Varian Pharmed
